Full Text Sources
The incidence of bullous pemphigoid is increasing recently, partly due to the increase of the use of certain culprit drugs, such as dipeptidyl peptidase-4 (DPP-4) inhibitors, psychotropic drugs, and checkpoint-inhibitors. DPP-4 inhibitors, a class of oral hypoglycemics, block the enzyme dipeptidyl peptidase-4, and can be used to treat diabetes mellitus type 2. Association of bullous pemphigoid and mucous membrane pemphigoid with DPP-4 inhibitors in patients with diabetes has been recently demonstrated. This article is protected by copyright. All rights reserved.
PMID: 30859617 [PubMed - as supplied by publisher]